head and neck squamous cell carcinoma
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:PD-L1
gptkb:nivolumab |
| gptkbp:affects |
head and neck region
|
| gptkbp:associated_with |
alcohol consumption
tobacco use |
| gptkbp:clinical_trial |
ongoing studies
new treatment options combination therapies |
| gptkbp:end_of_life |
varies by stage
higher in early stages lower in advanced stages |
| gptkbp:genetic_diversity |
gptkb:physicist
CDK N2 A mutation HRAS mutation PI K3 CA mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
head and neck squamous cell carcinoma
|
| gptkbp:is_popular_in |
increasing incidence
common in men |
| gptkbp:is_protected_by |
tobacco cessation
vaccination against HPV |
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:research_focus |
gptkb:vaccine
biomarkers targeted therapy |
| gptkbp:risk_factor |
human papillomavirus (HPV) infection
|
| gptkbp:social_responsibility |
imaging studies
biopsy depends on location depends on stage depends on treatment response associated with poor oral hygiene higher incidence in certain geographic regions linked to occupational exposure |
| gptkbp:symptoms |
sore throat
difficulty swallowing lump in the neck |
| gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy |
| gptkbp:type |
gptkb:nasopharyngeal_carcinoma
hypopharyngeal carcinoma laryngeal carcinoma oral cavity carcinoma oropharyngeal carcinoma |